These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2184486)

  • 21. A neuroleptic malignant-like syndrome (NMLS) in a patient with Parkinson's disease resolved with rotigotine: a case report.
    Fiore S; Persichino L; Anticoli S; De Pandis MF
    Acta Biomed; 2014 Dec; 85(3):281-4. PubMed ID: 25567468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sudden confusion with levodopa withdrawal.
    Lang AE
    Mov Disord; 1987; 2(3):223. PubMed ID: 3504551
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuroleptic malignant syndrome complicating levodopa withdrawal.
    Reutens DC; Harrison WB; Goldswain PR
    Med J Aust; 1991 Jul; 155(1):53-4. PubMed ID: 2067442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amantadine withdrawal and neuroleptic malignant syndrome.
    Weller M; Kornhuber J
    Neurology; 1993 Oct; 43(10):2155. PubMed ID: 8413995
    [No Abstract]   [Full Text] [Related]  

  • 25. Clozapine withdrawal symptoms in a Parkinson's disease patient.
    Zesiewicz TA; Borra S; Hauser RA
    Mov Disord; 2002 Nov; 17(6):1365-7. PubMed ID: 12465085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An uncommon adverse effect of levodopa withdrawal in a patient taking antipsychotic medication: neuroleptic malignant-like syndrome.
    Man SP
    Hong Kong Med J; 2011 Feb; 17(1):74-6. PubMed ID: 21282831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic malignant-like syndrome: case report.
    Tibbels CK; Seegers S
    Tex Med; 1988 May; 84(5):40-3. PubMed ID: 3406898
    [No Abstract]   [Full Text] [Related]  

  • 28. Malignant syndrome in Parkinson's disease: concept and review of the literature.
    Mizuno Y; Takubo H; Mizuta E; Kuno S
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S3-9. PubMed ID: 12735909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Withdrawal-induced neuroleptic malignant syndrome.
    Bower DJ; Chalasani P; Ammons JC
    Am J Psychiatry; 1994 Mar; 151(3):451-2. PubMed ID: 8109662
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal.
    Young CC; Kaufman BS
    J Clin Anesth; 1995 Dec; 7(8):652-6. PubMed ID: 8747565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autopsied case of Parkinson disease with neuroleptic malignant-like syndrome and rhabdomyolysis].
    Akai M; Ishizaki T; Idemura Y; Sasaki F; Nakai T; Miyaho S; Matsubara R; Uchiki H; Nakaguki K
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1863-4. PubMed ID: 1479229
    [No Abstract]   [Full Text] [Related]  

  • 32. Fever and rigidity.
    Howard ZD; Rempell JS; Nadel ES; Brown DF
    J Emerg Med; 2011 Jun; 40(6):668-70. PubMed ID: 21074960
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroleptic malignant syndrome in striatonigral degeneration.
    Gibb WR
    Br J Psychiatry; 1988 Aug; 153():254-5. PubMed ID: 3255444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporary levodopa withdrawal.
    N Engl J Med; 1986 Mar; 314(13):851-3. PubMed ID: 3951523
    [No Abstract]   [Full Text] [Related]  

  • 35. Neuroleptic malignant-like syndrome causing thrombocytopaenia: a rare association.
    Sahu H; Manjunath MB; Ray A; Vikram NK
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Withdrawal of levodopa and other risk factors for malignant syndrome in Parkinson's disease.
    Hashimoto T; Tokuda T; Hanyu N; Tabata K; Yanagisawa N
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S25-30. PubMed ID: 12735912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
    Hauser RA; Koller WC; Hubble JP; Malapira T; Busenbark K; Olanow CW
    Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatal hyperpyrexia after withdrawal of levodopa.
    Sechi GP; Tanda F; Mutani R
    Neurology; 1984 Feb; 34(2):249-51. PubMed ID: 6538021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period.
    Mizuta E; Yamasaki S; Nakatake M; Kuno S
    Neurology; 1993 May; 43(5):1048-9. PubMed ID: 7605396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-dopa and frontal cognitive function in Parkinson's disease.
    Lange KW; Paul GM; Robbins TW; Marsden CD
    Adv Neurol; 1993; 60():475-8. PubMed ID: 8420173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.